114 related articles for article (PubMed ID: 8364742)
1. Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys.
Schneider JS; Roeltgen DP
Brain Res; 1993 Jul; 615(2):351-4. PubMed ID: 8364742
[TBL] [Abstract][Full Text] [Related]
2. Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys.
Schneider JS; Kovelowski CJ
Brain Res; 1990 Jun; 519(1-2):122-8. PubMed ID: 2397401
[TBL] [Abstract][Full Text] [Related]
3. Nicotinic acetylcholine receptor agonist SIB-1508Y improves cognitive functioning in chronic low-dose MPTP-treated monkeys.
Schneider JS; Tinker JP; Van Velson M; Menzaghi F; Lloyd GK
J Pharmacol Exp Ther; 1999 Aug; 290(2):731-9. PubMed ID: 10411585
[TBL] [Abstract][Full Text] [Related]
4. Effects of the nicotinic acetylcholine receptor agonist SIB-1508Y on object retrieval performance in MPTP-treated monkeys: comparison with levodopa treatment.
Schneider JS; Van Velson M; Menzaghi F; Lloyd GK
Ann Neurol; 1998 Mar; 43(3):311-7. PubMed ID: 9506547
[TBL] [Abstract][Full Text] [Related]
5. Frontal cognitive impairments and saccadic deficits in low-dose MPTP-treated monkeys.
Slovin H; Abeles M; Vaadia E; Haalman I; Prut Y; Bergman H
J Neurophysiol; 1999 Feb; 81(2):858-74. PubMed ID: 10036286
[TBL] [Abstract][Full Text] [Related]
6. Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey.
Schneider JS; Pope-Coleman A
Neurodegeneration; 1995 Sep; 4(3):245-55. PubMed ID: 8581557
[TBL] [Abstract][Full Text] [Related]
7. Task persistence and learning ability in normal and chronic low dose MPTP-treated monkeys.
Roeltgen DP; Schneider JS
Behav Brain Res; 1994 Feb; 60(2):115-24. PubMed ID: 8003241
[TBL] [Abstract][Full Text] [Related]
8. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys.
Taylor JR; Elsworth JD; Roth RH; Sladek JR; Redmond DE
Brain; 1990 Jun; 113 ( Pt 3)():617-37. PubMed ID: 2364263
[TBL] [Abstract][Full Text] [Related]
9. Differences in alpha7 nicotinic acetylcholine receptor binding in motor symptomatic and asymptomatic MPTP-treated monkeys.
Kulak JM; Schneider JS
Brain Res; 2004 Mar; 999(2):193-202. PubMed ID: 14759498
[TBL] [Abstract][Full Text] [Related]
10. Effects of the prolyl endopeptidase inhibitor S 17092 on cognitive deficits in chronic low dose MPTP-treated monkeys.
Schneider JS; Giardiniere M; Morain P
Neuropsychopharmacology; 2002 Feb; 26(2):176-82. PubMed ID: 11790513
[TBL] [Abstract][Full Text] [Related]
11. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced acute transient dystonia in monkeys associated with low striatal dopamine.
Tabbal SD; Mink JW; Antenor JA; Carl JL; Moerlein SM; Perlmutter JS
Neuroscience; 2006 Sep; 141(3):1281-7. PubMed ID: 16766129
[TBL] [Abstract][Full Text] [Related]
12. Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier.
Taylor JR; Roth RH; Sladek JR; Redmond DE
Behav Neurosci; 1990 Aug; 104(4):564-76. PubMed ID: 2206426
[TBL] [Abstract][Full Text] [Related]
13. Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys.
Schneider JS; Sun ZQ; Roeltgen DP
Brain Res; 1994 Nov; 663(1):140-4. PubMed ID: 7850462
[TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to low doses of MPTP. II. Neurochemical and pathological consequences in cognitively-impaired, motor asymptomatic monkeys.
Schneider JS
Brain Res; 1990 Nov; 534(1-2):25-36. PubMed ID: 2073585
[TBL] [Abstract][Full Text] [Related]
15. Effects of nicotinic therapies on attention and executive functions in chronic low-dose MPTP-treated monkeys.
Decamp E; Schneider JS
Eur J Neurosci; 2006 Oct; 24(7):2098-104. PubMed ID: 17067307
[TBL] [Abstract][Full Text] [Related]
16. Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice.
Leng A; Mura A; Hengerer B; Feldon J; Ferger B
Behav Brain Res; 2004 Oct; 154(2):375-83. PubMed ID: 15313025
[TBL] [Abstract][Full Text] [Related]
17. Effects of the partial glycine agonist D-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys.
Schneider JS; Tinker JP; Van Velson M; Giardiniere M
Brain Res; 2000 Mar; 860(1-2):190-4. PubMed ID: 10727642
[TBL] [Abstract][Full Text] [Related]
18. Circadian determinations of cortisol, prolactin and melatonin in chronic methyl-phenyl-tetrahydropyridine-treated monkeys.
Barcia C; Bautista V; Sánchez-Bahillo A; Fernández-Villalba E; Navarro-Ruis JM; Barreiro AF; Poza Y Poza M; Herrero MT
Neuroendocrinology; 2003 Aug; 78(2):118-28. PubMed ID: 12915764
[TBL] [Abstract][Full Text] [Related]
19. The subtype-selective nicotinic acetylcholine receptor agonist SIB-1553A improves both attention and memory components of a spatial working memory task in chronic low dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.
Schneider JS; Tinker JP; Menzaghi F; Lloyd GK
J Pharmacol Exp Ther; 2003 Jul; 306(1):401-6. PubMed ID: 12721323
[TBL] [Abstract][Full Text] [Related]
20. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.
Pflibsen L; Stang KA; Sconce MD; Wilson VB; Hood RL; Meshul CK; Mitchell SH
J Neurosci Res; 2015 Dec; 93(12):1849-64. PubMed ID: 26332770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
